Pharmaceuticals,
Journal Year:
2023,
Volume and Issue:
16(4), P. 547 - 547
Published: April 5, 2023
In
the
past
two
decades,
drug
candidates
with
a
covalent
binding
mode
have
gained
interest
of
medicinal
chemists,
as
several
anticancer
drugs
successfully
reached
clinic.
As
changes
relevant
parameters
to
rank
inhibitor
potency
and
investigate
structure-activity
relationship
(SAR),
it
is
important
gather
experimental
evidence
on
existence
protein-drug
adduct.
this
work,
we
review
established
methods
technologies
for
direct
detection
adduct,
illustrated
examples
from
(recent)
development
endeavors.
These
include
subjecting
mass
spectrometric
(MS)
analysis,
protein
crystallography,
or
monitoring
intrinsic
spectroscopic
properties
ligand
upon
adduct
formation.
Alternatively,
chemical
modification
required
detect
adducts
by
NMR
analysis
activity-based
profiling
(ABPP).
Some
techniques
are
more
informative
than
others
can
also
elucidate
modified
amino
acid
residue
bond
layout.
We
will
discuss
compatibility
these
reversible
modes
possibilities
evaluate
reversibility
obtain
kinetic
parameters.
Finally,
expand
current
challenges
future
applications.
Overall,
analytical
present
an
integral
part
in
exciting
new
era
discovery.
Chemical Reviews,
Journal Year:
2020,
Volume and Issue:
121(12), P. 7155 - 7177
Published: Oct. 12, 2020
Click
chemistry,
proposed
nearly
20
years
ago,
promised
access
to
novel
chemical
space
by
empowering
combinatorial
library
synthesis
with
a
"few
good
reactions".
These
click
reactions
fulfilled
key
criteria
(broad
scope,
quantitative
yield,
abundant
starting
material,
mild
reaction
conditions,
and
high
chemoselectivity),
keeping
the
focus
on
molecules
that
would
be
easy
make,
yet
structurally
diverse.
This
philosophy
bears
striking
resemblance
DNA-encoded
(DEL)
technology,
now-dominant
chemistry
paradigm.
review
highlights
similarities
between
DEL
design
deployment
in
settings,
providing
framework
for
of
new
technologies
enable
next-generation
drug
discovery.
Chemical Science,
Journal Year:
2021,
Volume and Issue:
12(24), P. 8288 - 8310
Published: Jan. 1, 2021
This
review
highlights
the
recent
advances
in
use
of
activity-based
probes
(ABPs)
and
affinity-based
(AfBPs),
summarizes
their
design
strategies
(based
on
inhibitors
substrates)
detection
approaches.
Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
67(10), P. 7668 - 7758
Published: May 7, 2024
Covalent
inhibitors
and
other
types
of
covalent
modalities
have
seen
a
revival
in
the
past
two
decades,
with
variety
new
targeted
drugs
having
been
approved
recent
years.
A
key
feature
such
molecules
is
an
intrinsically
reactive
group,
typically
weak
electrophile,
which
enables
irreversible
or
reversible
formation
bond
specific
amino
acid
target
protein.
This
often
called
"warhead",
critical
determinant
ligand's
activity,
selectivity,
general
biological
properties.
In
2019,
we
summarized
emerging
re-emerging
warhead
chemistries
to
cysteine
acids
(Gehringer,
M.;
Laufer,
S.
A.
J.
Med.
Chem.
62,
5673−5724;
DOI:
10.1021/acs.jmedchem.8b01153).
Since
then,
field
has
rapidly
evolved.
Here
discuss
progress
on
warheads
made
since
our
last
Perspective
their
application
medicinal
chemistry
chemical
biology.
ACS Chemical Biology,
Journal Year:
2023,
Volume and Issue:
18(2), P. 285 - 295
Published: Jan. 17, 2023
Here,
we
report
a
comprehensive
profiling
of
sulfur(VI)
fluorides
(SVI-Fs)
as
reactive
groups
for
chemical
biology
applications.
SVI-Fs
are
functionalities
that
modify
lysine,
tyrosine,
histidine,
and
serine
sidechains.
A
panel
were
studied
with
respect
to
hydrolytic
stability
reactivity
nucleophilic
amino
acid
The
use
covalently
carbonic
anhydrase
II
(CAII)
range
kinases
was
then
investigated.
Finally,
the
SVI-F
used
in
live
cell
chemoproteomic
workflows,
identifying
novel
protein
targets
based
on
type
used.
This
work
highlights
how
can
be
tool
expand
liganded
proteome.
Nature Chemical Biology,
Journal Year:
2024,
Volume and Issue:
20(9), P. 1114 - 1122
Published: March 5, 2024
K-Ras
is
the
most
commonly
mutated
oncogene
in
human
cancer.
The
recently
approved
non-small
cell
lung
cancer
drugs
sotorasib
and
adagrasib
covalently
capture
an
acquired
cysteine
K-Ras-G12C
mutation
lock
it
a
signaling-incompetent
state.
However,
covalent
inhibition
of
G12D,
frequent
particularly
prevalent
pancreatic
ductal
adenocarcinoma,
has
remained
elusive
due
to
lack
aspartate-targeting
chemistry.
Here
we
present
set
malolactone-based
electrophiles
that
exploit
ring
strain
crosslink
K-Ras-G12D
at
mutant
aspartate
form
stable
complexes.
Structural
insights
from
X-ray
crystallography
exploitation
stereoelectronic
requirements
for
attack
electrophile
allowed
development
substituted
malolactone
resisted
by
aqueous
buffer
but
rapidly
crosslinked
with
aspartate-12
both
GDP
GTP
GTP-state
targeting
effective
suppression
downstream
signaling,
selective
K-Ras-G12D-driven
proliferation
vitro
xenograft
growth
mice.
Journal of Chemical Information and Modeling,
Journal Year:
2018,
Volume and Issue:
58(7), P. 1441 - 1458
Published: June 11, 2018
Increased
interest
in
covalent
drug
discovery
led
to
the
development
of
computer
programs
predicting
binding
mode
and
affinity
inhibitors.
Here
we
compare
performance
six
docking
tools,
AutoDock4,
CovDock,
FITTED,
GOLD,
ICM-Pro,
MOE,
for
reproducing
experimental
modes
an
unprecedently
large
diverse
set
complexes.
It
was
found
that
40–60%
top
scoring
ligand
poses
are
within
2.0
Å
RMSD
from
mode.
This
rate
showed
program
dependent
increase
achieved
50–90%
when
best
among
ten
considered.
is
comparable
noncovalent
tools
therefore
suggests
anchoring
does
not
necessarily
improve
accuracy
prediction.
The
effect
various
protein
features
on
investigated.
At
level
warhead
chemistry,
higher
success
Michael
additions,
nucleophilic
additions
substitutions
than
ring
opening
reactions
disulfide
formation.
Increasing
size
flexibility
generally
affects
pose
predictions
unfavorably,
although
ICM-Pro
were
be
less
sensitive
up
35
heavy
atoms.
accessibility
target
cysteine
tends
result
improved
predictions.
Docking
show
suggesting
a
target-dependent
choice
optimal
tool.
into
Cys/Ala
mutated
proteins
by
Glide
reproduced
with
only
slightly
lower
at
significantly
computational
expense
did.
Overall,
our
results
highlight
key
factors
influencing
investigated
they
give
guidelines
selecting
combination
warheads,
ligands,
system
Results
also
identify
most
important
aspects
considered
developing
protocols
virtual
screening
ligands.
Future Medicinal Chemistry,
Journal Year:
2020,
Volume and Issue:
13(2), P. 193 - 210
Published: Dec. 4, 2020
In
the
first
decade
of
targeted
covalent
inhibition,
scientists
have
successfully
reversed
previous
trend
that
had
impeded
use
inhibition
in
drug
development.
Successes
clinic,
mainly
field
kinase
inhibitors,
are
existing
proof
safe
inhibitors
can
be
designed
and
employed
to
develop
effective
treatments.
The
case
KRASG12C
entering
clinical
trials
2019
has
been
among
hottest
topics
discussed
discovery,
raising
expectations
for
future
field.
this
perspective,
an
overview
milestones
hit
with
as
well
promise
needs
current
research,
presented.
While
recent
results
confirmed
potential
was
foreseen,
many
questions
remain
unexplored
branch
precision
medicine.
iScience,
Journal Year:
2021,
Volume and Issue:
24(2), P. 102021 - 102021
Published: Jan. 10, 2021
The
unparalleled
global
effort
to
combat
the
continuing
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
pandemic
over
last
year
has
resulted
in
promising
prophylactic
measures.
However,
a
need
still
exists
for
cheap,
effective
therapeutics,
and
targeting
multiple
points
viral
life
cycle
could
help
tackle
current,
as
well
future,
coronaviruses.
Here,
we
leverage
our
recently
developed,
ultra-large-scale
silico
screening
platform,
VirtualFlow,
search
inhibitors
that
target
SARS-CoV-2.
In
this
unprecedented
structure-based
virtual
campaign,
screened
roughly
1
billion
molecules
against
each
of
40
different
sites
on
17
potential
host
targets.
addition
active
enzymes,
also
targeted
critical
auxiliary
such
functionally
important
protein-protein
interactions.